硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗 MDM4 磁珠
蛋白与多肽

抗 MDM4 磁珠

02AB00085

MDM4 is a critical regulator of the tumor suppressor protein p53, playing a significant role in cellular functions and disease mechanisms. It negatively regulates p53 activity, thereby influencing cell growth, stress responses, and apoptosis. MDM4's dysregulation is associated with various cancers, as it can lead to diminished p53 function, allowing uncontrolled cell proliferation. Studies have shown that loss-of-function mutations in MDM4 result in p53 hyperactivity, which can lead to hematological disorders, such as bone marrow failure. Additionally, MDM4 interacts with MDM2, another key regulator of p53, forming a complex network that governs p53's stability and activity. Targeting MDM4 for therapeutic interventions is being explored to restore p53 function in cancer and other diseases, highlighting its potential as a promising target for cancer therapies.

Human
规格起售价
登录后可查看

技术参数

宿主
Mouse
靶点基因名
MDM4
基因别名
MDMX
蛋白别名
MDM4 regulator of p53; MDM4
UniProt
O15151
物种
Human
应用
IP
Monoclonal
IgG1

产品详情

靶点名称
MDM4
蛋白名称
MDM4 regulator of p53
蛋白别名
Protein Mdm4; Double minute 4 protein; Mdm2-like p53-binding protein; Protein Mdmx; p53-binding protein Mdm4
靶点基因名
MDM4
基因别名
MDMX
UniProt
O15151
来源物种
Homo sapiens (Human)
宿主物种
Mouse
物种反应性
Human
克隆性
Monoclonal
亚型
IgG1
配方
Supplied as solution in phosphate buffered saline containing 0.1% BSA and 0.02% sodium azide
剂型
Subject to solid-liquid separation upon standing; Mix thoroughly to ensure a consistent, homogeneous

免疫原核心序列

TATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSRLDLGFEEWDVAGLPWWFLGNLRSNYTPRSNGSTDLQTNQDVGTAIVSDTTDDLWFLNESVSEQLGVGIKVEAADTEQTSEEVGKVSDKKVIEVGKNDDLEDSKSLSDDTDVEVTSEDEWQCTECKKFNSPSKRYCFRCWALRKDWYSDCSKLTHSLSTSDITAIPEKENEGNDVPDCRRTISAPVVRPKDAYIKKENSKLFDPCNSVEFLDLAHSSESQETISSMGEQLDNLSEQRTDTENMEDCQNLLKPCSLCEKRPRDGNIIHGRTGHLVTCFHCARRLKKAGASCPICKKE

应用推荐稀释比备注
IP—50-100 μL/200 μg cell lysate

背景介绍

MDM4 is a critical regulator of the tumor suppressor protein p53, playing a significant role in cellular functions and disease mechanisms. It negatively regulates p53 activity, thereby influencing cell growth, stress responses, and apoptosis. MDM4's dysregulation is associated with various cancers, as it can lead to diminished p53 function, allowing uncontrolled cell proliferation. Studies have shown that loss-of-function mutations in MDM4 result in p53 hyperactivity, which can lead to hematological disorders, such as bone marrow failure. Additionally, MDM4 interacts with MDM2, another key regulator of p53, forming a complex network that governs p53's stability and activity. Targeting MDM4 for therapeutic interventions is being explored to restore p53 function in cancer and other diseases, highlighting its potential as a promising target for cancer therapies.